Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Lobe Sciences (LOBE) Stock Price & Analysis

LOBE Stock Chart & Stats

€0.02€0.00(0.00%)
At close: 5:30 PM GMT+1
€0.06€0.065€0.07€0.0759 Jun6 Aug
Day’s Range
EUR 0.02 - EUR 0.02
52-Week Range
EUR 0.01 - EUR 0.08
Previous Close
EUR 0.02
Volume
0
Average Volume (3M)
0
Market Cap
EUR 8.89M
Enterprise Value
EUR 25.61M
Total Cash (Recent Filing)
EUR 5.21M
Total Debt (Recent Filing)
EUR 338.40K
Price to Earnings (P/E)
―
Beta
2.48
Next Earnings
Dec 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Equity Stabilization

The return to positive equity marks a meaningful improvement from the company’s earlier balance-sheet weakness. Although capital remains volatile, this stabilization provides a stronger base for financing, partnerships, and continued development than the negative-equity position reported in prior years.

Modest Absolute Debt

Relatively low absolute debt limits the fixed obligations directly burdening the business and reduces dependence on substantial interest-bearing financing. This offers some financial flexibility while the company works to develop operations, even though shrinking equity makes leverage more significant.

Prior Gross Profit Potential

The strong FY2024 gross-profit share indicates that the company previously demonstrated potentially attractive economics on the revenue it generated. If commercial activity is re-established, that historical margin profile could support operating leverage, although current zero revenue means it is not presently being realized.

Bears Say

No Current Revenue

The absence of current revenue shows that Lobe Sciences does not presently have a functioning commercial revenue base supporting its operations. This weakens visibility into future self-funded growth and leaves successful development, commercialization, or partnering as essential to rebuilding durable earnings capacity.

Worsening Operating Losses

Widening operating losses despite zero revenue indicate that the company continues consuming resources without corresponding commercial output. Persistent losses can erode the capital base, constrain investment in development, and increase the likelihood that future progress requires external financing.

Increasing Cash Burn

Cash generation is materially negative and has deteriorated from the prior fiscal year, demonstrating limited ability to fund operations internally. Continued burn raises financing risk over the medium term and may force the company to prioritize capital preservation over research, development, or commercialization efforts.

Lobe Sciences News

LOBE FAQ

What was Lobe Sciences’s price range in the past 12 months?
Lobe Sciences lowest stock price was €0.01 and its highest was €0.08 in the past 12 months.
What is Lobe Sciences’s market cap?
Lobe Sciences’s market cap is €8.89M.
When is Lobe Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lobe Sciences’s earnings last quarter?
Lobe Sciences released its earnings results on Jul 30, 2026. The company reported -€0.001 earnings per share for the quarter.
Is Lobe Sciences overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Lobe Sciences pay dividends?
Lobe Sciences does not currently pay dividends.
What is Lobe Sciences’s EPS estimate?
Lobe Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lobe Sciences have?
Lobe Sciences has 308,182,160 shares outstanding.
What happened to Lobe Sciences’s price movement after its last earnings report?
Lobe Sciences reported an EPS of -€0.001 in its last earnings report. Following the earnings report the stock price went down -26%.
Which hedge fund is a major shareholder of Lobe Sciences?
Currently, no hedge funds are holding shares in DE:LOBE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology